Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia

Study Identifier
191622-090
CT.gov Identifier
NCT00564681
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Movement Disorders - Other
    • Study Drug
  • botulinum toxin type A
  • botulinum toxin type A Formulation 2
  • Normal Saline
    • Phase
    Phase 2
    Sex
    Female & Male
    Age
    18 - 75 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Diagnosis of cervical dystonia
    Exclusion Criteria:
    * Current or previous botulinum toxin treatment of any type for any condition

    Protocol Summary

    Study is to investigate the use of the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) scale in a cervical dystonia population treated with botulinum toxin type A, and placebo.

    Study Locations

    Location
    Status
    Location
    Winston-Salem, North Carolina, United States
    Status
    Not applicable
    Location
    Halifax, Nova Scotia, Canada
    Status
    Not applicable
    Location
    Prague, Czech Republic
    Status
    Not applicable
    Location
    Berlin, Germany
    Status
    Not applicable
    Location
    Budapest, Hungary
    Status
    Not applicable
    Location
    Mumbai, India
    Status
    Not applicable
    Showing {first} - {last} of {total} Results